INTERNATIONAL PATENT: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, 서울대학교 산학협력단, DEEPSONBIO CO., LTD., 주식회사 딥슨바이오 FILES APPLICATION FOR "METHOD FOR CONFIRMING DRUG PERMEABILITY AND CANCER CELL APOPTOSIS OF CHOLANGIOCARCINOMA BY IRRADIATION OF LOW INTENSITY PULSED ULTRASOUND (LIPUS) UNDER TUMOR MICROENVIRONMENT AND COMBINATION REGIMEN OF GEMCITABINE AND CISPLATIN WITH LOW INTENSITY PULSED ULTRASOUND FOR INHIBITING CHOLANGIOCARCINOMA GROWTH"
GENEVA, May 5 -- SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (1 Gwanak-ro,Gwanak-gu,Seoul 08826), 서울대학교 산학협력단 (서울특별시관악구관악로 1), DEEPSONBIO CO., LTD. (6F, 172 Dolma-ro,Bundang-gu, Seongnam-si,Gyeonggi-do 13605), 주식회사 딥슨바이오 (경기도성남시 분당구돌마로 172, 6층) filed a patent application (PCT/KR2025/015024) for "METHOD FOR CONFIRMING DRUG PERMEABILITY AND CANCER CELL APOPTOSIS OF CHOLANGIOCARCINOMA BY IRRADIATION OF LOW INTENSITY PULSED ULTRASOUND (LIPUS) UNDER TU...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.